- Home
- ANTX vs CHEC Comparison
ANTX vs CHEC Comparison
Compare ANTX & CHEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
BUY
Current Price
$3.59
Company Overview
Basic Information| Metric | ANTX | CHEC |
|---|---|---|
| Founded | 2017 | 2024 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.9M | 175.5M |
| IPO Year | 2022 | 2025 |
Fundamental Metrics
Financial Performance| Metric | ANTX | CHEC |
|---|---|---|
| Price | $3.59 | $10.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 306.3K | 63.3K |
| Earning Date | 11-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $9.91 |
| 52 Week High | $7.19 | $10.56 |
Technical Indicators
Market Signals| Indicator | ANTX | CHEC |
|---|---|---|
| Relative Strength Index (RSI) | 21.92 | 65.09 |
| Support Level | $2.87 | $10.22 |
| Resistance Level | $5.21 | $10.47 |
| Average True Range (ATR) | 0.40 | 0.01 |
| MACD | -0.17 | 0.00 |
| Stochastic Oscillator | 2.34 | 100.00 |
Price Performance
Historical Comparison ANTX
CHEC
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
About CHEC Chenghe Acquisition III Co. Class A Ordinary Share
Chenghe Acquisition III Co is blank check company.